Dr. Aliesha O’Raw, Terasaki Principal Investigator, Selected for 2026 ACS BrightEdge Entrepreneurs Program Cohort
In a significant development within the cancer research community, the Terasaki Institute for Biomedical Innovation (TIBI) has proudly revealed that ...

